WHWeilin Hou

Weilin Hou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weilin Hou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Chunli Cai

    Operation Department, Shenzhen Yilanda Technology Co. Ltd., Shenzhen, China

    1 shared publication
  • Fang Liu

    Department of Rehabilitation, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University Health Science Centre, Shenzhen, China

    1 shared publication
  • Guohui Nie

    Department of Otolaryngology Head & Neck Surgery, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, China

    1 shared publication
  • Jianjun Long

    Department of Rehabilitation, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University Health Science Centre, Shenzhen, China

    1 shared publication
  • Jiehui Li

    Department of Rehabilitation, The Second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University Health Science Centre, Shenzhen, China

    1 shared publication
  • John Wong

    School of Nursing and Department of Occupational Therapy, MGH Institute of Health Professions, Boston, USA

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of activities of daily living using an electronic version of the Longshi Scale in patients with stroke: reliability, consistency, and preference

    by Kaiwen Xue, Weihao Li, Fang Liu, Xiangxiang Liu, John Wong, Mingchao Zhou, Chunli Cai, Jianjun Long, Jiehui Li, Zeyu Zhang, et al.

    Background: The Longshi Scale is a pictorial assessment tool for evaluating activities of daily living (ADL) in patients with stroke. The paper-based version presents challenges; thus, the WeChat version was created to enhance accessibility. Herein, we aimed to validate the inter-rater and test–retest reliabilities of the WeChat version of the Longshi Scale and explore its potential clinical applications.Methods: We recruited 115 patients with stroke in the study. The ADL results of each patient were assessed using both the WeChat and paper-based version of the Longshi Scale; each evaluation was conducted by 28 health professionals and 115 caregivers separately. To explore the test–retest reliability of the WeChat version, 22 patients were randomly selected and re-evaluated by health professionals using the WeChat version. All evaluation criteria were recorded, and all evaluators were surveyed to indicate their preference between the two versions.Results: Consistency between WeChat and the paper-based Longshi Scale was high for ADL scores by health professionals (ICC2,1 = 0.803–0.988) and caregivers (ICC2,1 = 0.845–0.983), as well as for degrees of disability (κw = 0.870 by professionals; κw = 0.800 by caregivers). Bland–Altman analysis showed no significant discrepancies. The WeChat version exhibited good test–retest reliability (κw = 0.880). The WeChat version showed similar inter-rater reliability in terms of the ADL score evaluated using the paper-based version (ICC2,1 = 0.781–0.941). The time to complete assessments did not differ significantly, although the WeChat version had a shorter information entry time (P < 0.001, 95% confidence interval: –43.463 to –15.488). Health professionals favored the WeChat version (53.6%), whereas caregivers had no significant preference.Conclusions: The WeChat version of the Longshi Scale is reliable and serves as a suitable alternative for health professionals and caregivers to assess ADL levels in patients with stroke. The WeChat version of the Longshi Scale is considered user-friendly by health professionals, although it is not preferred by caregivers.Trial registration: This study was approved by the Ethics Committee of the Second People’s Hospital of Shenzhen (approval number: 20210812003-FS01) and registered on the Clinical Trial Register Center website: clinicaltrials.gov on January 31, 2022 (registration no.: NCT05214638).